AU2003201281A1 - Antimicrobial peptides and derived metapeptides - Google Patents

Antimicrobial peptides and derived metapeptides

Info

Publication number
AU2003201281A1
AU2003201281A1 AU2003201281A AU2003201281A AU2003201281A1 AU 2003201281 A1 AU2003201281 A1 AU 2003201281A1 AU 2003201281 A AU2003201281 A AU 2003201281A AU 2003201281 A AU2003201281 A AU 2003201281A AU 2003201281 A1 AU2003201281 A1 AU 2003201281A1
Authority
AU
Australia
Prior art keywords
antimicrobial peptides
metapeptides
derived
derived metapeptides
antimicrobial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2003201281A
Other versions
AU2003201281B2 (en
Inventor
Alexander J. Shen
Michael R. Yeaman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harbor Ucla Medical Center
Original Assignee
Harbor Ucla Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU26836/99A external-priority patent/AU2683699A/en
Application filed by Harbor Ucla Medical Center filed Critical Harbor Ucla Medical Center
Priority to AU2003201281A priority Critical patent/AU2003201281B2/en
Publication of AU2003201281A1 publication Critical patent/AU2003201281A1/en
Assigned to LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER reassignment LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE AT HARBOR-UCLA MEDICAL CENTER Amend patent request/document other than specification (104) Assignors: HARBOR-UCLA RESEARCH AND EDUCATION INSTITUTE
Application granted granted Critical
Publication of AU2003201281B2 publication Critical patent/AU2003201281B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2003201281A 1998-02-18 2003-03-12 Antimicrobial peptides and derived metapeptides Ceased AU2003201281B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003201281A AU2003201281B2 (en) 1998-02-18 2003-03-12 Antimicrobial peptides and derived metapeptides

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2531998A 1998-02-18 1998-02-18
US09025319 1998-02-18
AU26836/99A AU2683699A (en) 1998-02-18 1999-02-17 Antimicrobial peptides and derived metapeptides
AU2003201281A AU2003201281B2 (en) 1998-02-18 2003-03-12 Antimicrobial peptides and derived metapeptides

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU26836/99A Division AU2683699A (en) 1998-02-18 1999-02-17 Antimicrobial peptides and derived metapeptides

Publications (2)

Publication Number Publication Date
AU2003201281A1 true AU2003201281A1 (en) 2003-06-12
AU2003201281B2 AU2003201281B2 (en) 2009-01-08

Family

ID=21825340

Family Applications (2)

Application Number Title Priority Date Filing Date
AU26836/99A Abandoned AU2683699A (en) 1998-02-18 1999-02-17 Antimicrobial peptides and derived metapeptides
AU2003201281A Ceased AU2003201281B2 (en) 1998-02-18 2003-03-12 Antimicrobial peptides and derived metapeptides

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU26836/99A Abandoned AU2683699A (en) 1998-02-18 1999-02-17 Antimicrobial peptides and derived metapeptides

Country Status (6)

Country Link
US (1) US6743769B1 (en)
EP (1) EP1056465A4 (en)
JP (1) JP2002503701A (en)
AU (2) AU2683699A (en)
CA (1) CA2320429C (en)
WO (1) WO1999042119A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820619B1 (en) * 1998-02-18 2010-10-26 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Antimicrobial peptides and derived metapeptides
WO1999042119A1 (en) 1998-02-18 1999-08-26 Harbor-Ucla Research And Education Institute Antimicrobial peptides and derived metapeptides
IT1317836B1 (en) * 2000-02-16 2003-07-15 Zambon Spa USE OF TIAMFENICOLO FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF STAPHYLOCOCCI INFECTIONS
US6632616B2 (en) * 2000-03-16 2003-10-14 Duke University Compounds that selectively bind to expanded polyglutamine repeat domains and methods of use thereof
US20040198950A1 (en) 2001-04-30 2004-10-07 George Jackowski Biopolymer marker indicative of disease state having a molecular weight of 1518 daltons
EP1478665A2 (en) * 2002-02-19 2004-11-24 Novartis AG Organic compounds having anti-angiogenic activity
AU2003231879A1 (en) * 2002-05-28 2003-12-12 The Trustees Of The University Of Pennsylvania Methods, systems, and computer program products for computational analysis and design of amphiphilic polymers
US7067621B2 (en) 2002-08-20 2006-06-27 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Multifunctional context-activated protides and methods of use
JP2010516688A (en) * 2007-01-16 2010-05-20 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Antibacterial peptide
ES2773766T3 (en) 2008-12-19 2020-07-14 Baxalta GmbH TFPI inhibitors and methods of use
WO2011103567A2 (en) 2010-02-22 2011-08-25 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Peptides and methods for inducing cell death
AU2011227714B2 (en) 2010-03-19 2014-09-04 Takeda Pharmaceutical Company Limited TFPI inhibitors and methods of use
EP3384938A1 (en) 2011-09-12 2018-10-10 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
KR101345333B1 (en) * 2011-12-30 2013-12-30 조선대학교산학협력단 Novel antibiotic and antimycotic peptide with four times repeated Lys and Trp residues and use therof
CA2867363C (en) 2012-03-21 2023-02-28 Baxter International Inc. Tfpi inhibitors and methods of use
AU2013243946A1 (en) 2012-04-02 2014-10-30 Moderna Therapeutics, Inc. Modified polynucleotides for the production of membrane proteins
AU2013243949A1 (en) 2012-04-02 2014-10-30 Moderna Therapeutics, Inc. Modified polynucleotides for the production of biologics and proteins associated with human disease
US11168131B2 (en) 2015-11-10 2021-11-09 Visterra, Inc. Antibody molecule-drug conjugates and uses thereof
CA3049449A1 (en) 2017-01-18 2018-07-26 Visterra, Inc. Antibody molecule-drug conjugates and uses thereof
CN116710146A (en) 2020-04-03 2023-09-05 威特拉公司 Antibody molecule-drug conjugates and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ237202A (en) 1990-02-23 1994-01-26 Bristol Myers Squibb Co Composition containing beta-lactam antibiotic and cationic oligopeptide
US5834430A (en) * 1995-05-31 1998-11-10 Biosynth S.R.L. Potentiation of antibiotics
WO1999042119A1 (en) 1998-02-18 1999-08-26 Harbor-Ucla Research And Education Institute Antimicrobial peptides and derived metapeptides
WO2000018922A2 (en) 1998-10-01 2000-04-06 Incyte Genomics, Inc. Human carbohydrate-associated proteins
US6368793B1 (en) 1998-10-14 2002-04-09 Microgenomics, Inc. Metabolic selection methods
AU1744900A (en) 1998-11-23 2000-06-13 Incyte Pharmaceuticals, Inc. Gtpase associated proteins

Similar Documents

Publication Publication Date Title
AU4208799A (en) Interleukins-21 and 22
AU5220698A (en) Antimicrobial cationic peptides
AU2434199A (en) Protein
AU2003201281A1 (en) Antimicrobial peptides and derived metapeptides
AU9781998A (en) Huchordin and uses thereof
EP1056465A4 (en) Antimicrobial peptides and derived metapeptides
AU4198299A (en) Compounds and uses thereof
AU1884397A (en) Antifungic and antibacterial peptide
AU5091199A (en) Prion protein and uses thereof
GB9806806D0 (en) Peptides and uses thereof
AU4281999A (en) Peptide
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
AU8695298A (en) Compounds and uses thereof
AU1725299A (en) Antifungal and antibacterial peptides
AU2333099A (en) Aryloxyanilides and related compounds
AU4064699A (en) Insecticide
AU6163099A (en) Antifungal and antibacterial peptide
AUPP617598A0 (en) Genetic sequence and uses therefor
AU2136401A (en) P450rai-2 and related proteins
AU3930399A (en) Cyclosporin preparations
AU5979300A (en) Angiopoietin-6 and uses thereof
AU2227999A (en) Human ependymin
AU1552800A (en) Coupled peptides
AU3411999A (en) Novel rnase-like protein and its use
AU4992099A (en) Human presenilin-associated protein